AR112457A1 - Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona - Google Patents

Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona

Info

Publication number
AR112457A1
AR112457A1 ARP180101984A AR112457A1 AR 112457 A1 AR112457 A1 AR 112457A1 AR P180101984 A ARP180101984 A AR P180101984A AR 112457 A1 AR112457 A1 AR 112457A1
Authority
AR
Argentina
Prior art keywords
methyl
pirazin
triazolo
derivatives
cyclopropyl
Prior art date
Application number
Other languages
English (en)
Spanish (es)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR112457A1 publication Critical patent/AR112457A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/12Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
    • C07D471/14Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
ARP180101984 2017-08-02 2018-07-17 Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona AR112457A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201762540122P 2017-08-02 2017-08-02

Publications (1)

Publication Number Publication Date
AR112457A1 true AR112457A1 (es) 2019-10-30

Family

ID=63165529

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP180101984 AR112457A1 (es) 2017-08-02 2018-07-17 Derivados de [1,2,4]triazolo[4,3-a]pirazin-6(5h)-ona

Country Status (8)

Country Link
US (1) US11180503B2 (https=)
EP (1) EP3661936B1 (https=)
JP (1) JP6850396B2 (https=)
CN (1) CN110914268B (https=)
AR (1) AR112457A1 (https=)
ES (1) ES2904938T3 (https=)
TW (1) TWI670271B (https=)
WO (1) WO2019027783A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11453673B2 (en) 2018-02-06 2022-09-27 Eli Lilly And Company Substituted [1,2,4]triazolo[4,3-a]pyrazines as phosphodiesterase inhibitors
WO2025059641A1 (en) 2023-09-14 2025-03-20 Eli Lilly And Company Pde1 inhibitors

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4354027A (en) 1980-05-19 1982-10-12 Usv Pharmaceutical Corporation Triazoloquinoxalin-4-ones
MX2009000170A (es) * 2006-06-23 2009-01-23 Incyte Corp Derivados de purinona como agonistas de hm74a.
US8299080B2 (en) 2006-12-13 2012-10-30 Aska Pharmaceutical Co., Ltd. Substituted imidazo[1,5-A] quinoxalines as a PDE9 inhibitor
WO2008103357A1 (en) 2007-02-21 2008-08-28 E. I. Du Pont De Nemours And Company Fungicidal tricyclic 1,2,4-triazoles
EP2509983B1 (en) * 2009-11-16 2014-09-17 Merck Sharp & Dohme Corp. FUSED TRICYCLIC COMPOUNDS WITH ADENOSINE A2a RECEPTOR ANTAGONIST ACTIVITY
KR20130097178A (ko) 2010-09-07 2013-09-02 아스텔라스세이야쿠 가부시키가이샤 퀴녹살린 화합물
CN103874701A (zh) * 2011-09-09 2014-06-18 H.隆德贝克有限公司 吡啶化合物和其用途
CA2877146C (en) 2012-06-18 2020-10-20 Dart Neuroscience (Cayman) Ltd Substituted thiophene- and furan-fused azolopyrimidine-5-(6h)-one compounds
US20140045856A1 (en) * 2012-07-31 2014-02-13 Boehringer Ingelheim International Gmbh 4-Methyl-2,3,5,9,9b-pentaaza-cyclopenta[a]naphthalenes
TW201629064A (zh) * 2014-10-10 2016-08-16 H 朗德貝克公司 作爲pde1抑制劑之三唑並吡酮
TWI609870B (zh) * 2016-02-12 2018-01-01 美國禮來大藥廠 Pde1抑制劑
JOP20170164A1 (ar) * 2016-08-25 2019-01-30 Lilly Co Eli مشتق ترايازولو بيرازينون مفيد كمثبط لـ pde1 بشري

Also Published As

Publication number Publication date
EP3661936A1 (en) 2020-06-10
TW201920175A (zh) 2019-06-01
JP2020529413A (ja) 2020-10-08
JP6850396B2 (ja) 2021-03-31
EP3661936B1 (en) 2021-12-22
TWI670271B (zh) 2019-09-01
US20200123154A1 (en) 2020-04-23
WO2019027783A1 (en) 2019-02-07
ES2904938T3 (es) 2022-04-06
CN110914268B (zh) 2022-04-19
US11180503B2 (en) 2021-11-23
CN110914268A (zh) 2020-03-24

Similar Documents

Publication Publication Date Title
PE20221504A1 (es) Derivados de un inhibidor de fgfr
EA201991161A1 (ru) 7-фенилэтиламино-4h-пиримидо[4,5-d][1,3]оксазин-2-оновые соединения в качестве ингибиторов мутантных idh1 и idh2
MX2021013640A (es) Composiciones novedosas y metodos.
ES2609857T3 (es) 4-(8-metoxi-1-((1-metoxipropan-2-il)-2-(tetrahidro-2H-piran-4-il)-1H-imidazo[4,5-C]quinolin-7-il)-3,5-dimetilisoxazol y su uso como inhibidor de bromodominios
MX2022000244A (es) Pirrolo[2,3-b]pirazinas como inhibidores de hpk1 y uso de las mismas.
MX2023009524A (es) Formas solidas cristalinas de inhibidor de bromodominio y extra-terminal (bet).
CL2018002803A1 (es) Antagonistas de c5ar solubles
ECSP13012764A (es) COMPUESTO DE IMIDAZO[4,5-C]QUINOLIN-2-ONA Y SU USO COMO INHIBIDOR DUAL DE CINASA PI3/mTOR
UY37703A (es) Compuestos heteroarílicos bicíclicos 6-6 fusionados y su uso como inhibidores de lats
MX2023011675A (es) Beta-hidroxietilaminas heteroaril sustituidas para su uso en el tratamiento de hiperglucemia.
PH12016502252A1 (en) Addition salts of (s)-2-(1-(6-amino-5-cyanopyrimidin-4-ylamino)ethyl)-4-oxo-3-phenyl-3,4-dihydropyrrolo[1,2-f][1,2,4]triazine-5-carbonitrile
WO2014152029A3 (en) Oxazolo[5,4-c]quinolin-2-one compounds as bromodomain inhibitors
MX2023000418A (es) Fluorofenil beta-hidroxietilaminas y su uso en el tratamiento de la hiperglucemia.
CL2017003032A1 (es) Derivado de pirido[3,4-d]pirimidina y sal farmacéuticamente aceptable de éste
MX376174B (es) 1h-pirrolo[2,3-c]piridin-7(6h)-onas y pirazolo[3,4-c]piridin-7(6h)-onas como inhibidores de proteinas de bromodominio y extra terminal (bet).
CO6571861A2 (es) Derivado de 1,3,4,8-tetrahidro-2h-pirido[1,2-a]pirazina y su uso como inhibidor de la integrasa del vih
MX2020002814A (es) 7-bencil-4-(2-metilbencil)-2,4,6,7,8,9-hexahidroimidazo[1,2-a]pir ido[3,4-e]pirimidin-5(1h)-ona, sales de la misma y metodos de uso.
PE20152033A1 (es) Heterociclos bicicliclos como inhibidores de fgfr
BR112019024300A2 (pt) Ativadores de guanilato ciclase solúvel com modo duplo de ação e inibidores da fosfodiesterase e usos dos mesmos
MX391724B (es) Nuevos derivados de triazolo[4,5-d]pirimidina.
CO2020006907A2 (es) Péptidos antimicrobianos y métodos para usarlos
PE20170936A1 (es) Compuestos novedosos de imidazopiridazina y su uso
MX2019013383A (es) Agente terapeutico para la demencia que combina derivado de pirazoloquinolina y memantina.
PE20170683A1 (es) Triazolo[4,5-d]pirimidinas como agonistas del receptor canabinoide 2
UY37250A (es) Derivados macrocíclicos de indol

Legal Events

Date Code Title Description
FB Suspension of granting procedure